PrimeGen Biotech Corporation To Discuss Reprogramming Of Germ-Line Stem Cells Into Pluripotent Cells At Burnham Institute

IRVINE, Calif.--(BUSINESS WIRE)--May 9, 2006--Publicly addressing the company's breakthrough in stem cell research, PrimeGen Biotech LLC (www.primegenbiotech.com) today announced that its principal investigator will present data showing the isolation and therapeutic reprogramming of adult germ-line stem cells into pluripotent cells -- cells that have the potential to turn into any cell line of the body.
MORE ON THIS TOPIC